Evidence mapPaperPMID 41257281Full record

ReviewWorld journal of gastroenterology2025

Mechanisms of ferroptosis in primary hepatocellular carcinoma and progress of artificial intelligence-based predictive modeling in hepatocellular carcinoma.

Jiang-Feng Han, Zi-Yao Jia, Xiang Fan, Xue-Yan Zhao, Li-Ye Cheng, Yu-Xuan Xia, Xiao-Ran Ji, Wen-Qiao Zang

Abstract readReview
In one paragraph

Review in World journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jiang-Feng HanCollege of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450000, Henan Province, China.
Zi-Yao JiaThe First Clinical Medical College, Zhengzhou University, Zhengzhou 450052, Henan Province, China.
Xiang FanThe Fifth Clinical Medical College of Henan University of Chinese Medicine, Henan University of Chinese Medicine, Zhengzhou 450099, Henan Province, China.
Xue-Yan ZhaoSchool of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, Henan Province, China.
Li-Ye ChengThe Third Clinical Medical College, Zhengzhou University, Zhengzhou 450052, Henan Province, China.
Yu-Xuan XiaThe Fifth Clinical Medical College, Zhengzhou University, Zhengzhou 450052, Henan Province, China.
Xiao-Ran JiSchool of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, Henan Province, China.
Wen-Qiao ZangCollege of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450000, Henan Province, China. zangwenqiao@zzu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ferroptosis, an iron-dependent form of programmed cell death, has garnered significant attention in tumor research in recent years. Its core characteristics include aberrant accumulation of lipid peroxides and impairment of antioxidant defense mechanisms, such as dysfunction of glutathione peroxidase 4. These features are closely intertwined with the initiation, progression, and therapeutic resistance of hepatocellular carcinoma (HCC). This review presents a systematic overview of the fundamental molecular mechanisms underlying ferroptosis, encompassing iron metabolism, lipid metabolism, and the antioxidant system. Furthermore, it summarizes the potential applications of targeting ferroptosis in liver cancer treatment, including the mechanisms of action of anticancer agents (

Indexed as

Artificial IntelligenceCarcinoma, HepatocellularFerroptosisLiver NeoplasmsAntineoplastic AgentsBiomarkers, TumorDisease ProgressionEarly Detection of CancerHumansIronLipid MetabolismLiverAntineoplastic AgentsBiomarkers, TumorIronArtificial intelligence prediction modelFerroptosisFerroptosis-related enzymesFerroptosis-related noncoding RNAsLiver cancerSorafenib

Identifiers

PMID41257281
PMCPMC12620812

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.